- Podcast Series
- Targeted Therapies in Lung Cancer 2023
- ASCO® 2023
- Lung Cancer OncTalk
- Blood Cancer OncTalk
- 2022 Melanoma Video Library
- OncTalk 2022
- ASCO Lung Review 2022
- ASCO and ESMO Lung Recap
- 2021 Targeted Therapies Patient Forum
- COVID-19
- Lung
- Hematologic Oncology
- Head and Neck
- Brain
- Palliative
- Genitourinary
- General
- Breast
Playback speed
10 seconds
Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon Acquired Resistance to Osimertinib?
By
GRACE
FEATURING
Zofia Piotrowska
By
GRACE
FEATURING
Zofia Piotrowska
98 views
March 1, 2021
Login to view comments.
Click here to Login
Lung